PL3352745T3 - Połączenie dofetylidu i meksyletyny w zapobieganiu i leczeniu migotania przedsionków - Google Patents
Połączenie dofetylidu i meksyletyny w zapobieganiu i leczeniu migotania przedsionkówInfo
- Publication number
- PL3352745T3 PL3352745T3 PL16778591.4T PL16778591T PL3352745T3 PL 3352745 T3 PL3352745 T3 PL 3352745T3 PL 16778591 T PL16778591 T PL 16778591T PL 3352745 T3 PL3352745 T3 PL 3352745T3
- Authority
- PL
- Poland
- Prior art keywords
- dofetilide
- mexiletine
- prevention
- treatment
- combination
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562222973P | 2015-09-24 | 2015-09-24 | |
| US14/922,529 US9597302B1 (en) | 2015-09-24 | 2015-10-26 | Combination of dofetilide and mexiletine for the prevention and treatment of atrial fibrillation |
| PCT/US2016/053419 WO2017053782A1 (en) | 2015-09-24 | 2016-09-23 | Combination of dofetilide and mexiletine for the prevention and treatment of atrial fibrillation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3352745T3 true PL3352745T3 (pl) | 2022-08-01 |
Family
ID=58337113
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16778591.4T PL3352745T3 (pl) | 2015-09-24 | 2016-09-23 | Połączenie dofetylidu i meksyletyny w zapobieganiu i leczeniu migotania przedsionków |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9597302B1 (pl) |
| EP (1) | EP3352745B1 (pl) |
| JP (1) | JP6659833B2 (pl) |
| CN (1) | CN107205967B (pl) |
| ES (1) | ES2914060T3 (pl) |
| PL (1) | PL3352745T3 (pl) |
| WO (1) | WO2017053782A1 (pl) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11364213B2 (en) | 2018-06-25 | 2022-06-21 | Academic Pharmaceuticals Inc | Method of initiating or escalating dofetilide dose and formulations therefor |
| US11610660B1 (en) | 2021-08-20 | 2023-03-21 | AltaThera Pharmaceuticals LLC | Antiarrhythmic drug dosing methods, medical devices, and systems |
| US11344518B2 (en) | 2018-08-14 | 2022-05-31 | AltaThera Pharmaceuticals LLC | Method of converting atrial fibrillation to normal sinus rhythm and loading oral sotalol in a shortened time frame |
| US12396970B2 (en) | 2021-08-20 | 2025-08-26 | AltaThera Pharmaceuticals LLC | Anti-arrhythmic compositions and methods |
| US10512620B1 (en) | 2018-08-14 | 2019-12-24 | AltaThera Pharmaceuticals, LLC | Method of initiating and escalating sotalol hydrochloride dosing |
| US11696902B2 (en) | 2018-08-14 | 2023-07-11 | AltaThera Pharmaceuticals, LLC | Method of initiating and escalating sotalol hydrochloride dosing |
| US12117453B2 (en) | 2018-12-07 | 2024-10-15 | Washington University | Predicting patient response to sodium channel blockers |
| EP4247354A4 (en) * | 2020-11-18 | 2025-02-19 | Fb-Hrs, Llc | COMPOSITIONS CONTAINING DOFETILIDE AND MEXILETINE AND THEIR USES |
| WO2022133317A1 (en) * | 2020-12-17 | 2022-06-23 | Incarda Therapeutics, Inc. | Kits and methods for induction of cardioversion in subjects with atrial arrhythmias |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0898964A1 (en) * | 1997-08-19 | 1999-03-03 | Pfizer Inc. | Method for treating heart failure |
| JP2015504923A (ja) * | 2012-01-27 | 2015-02-16 | ギリアード サイエンシーズ， インコーポレイテッド | 後期ナトリウムイオンチャネル遮断剤およびカリウムイオンチャネル遮断剤を使用する併用療法 |
-
2015
- 2015-10-26 US US14/922,529 patent/US9597302B1/en active Active
-
2016
- 2016-09-23 CN CN201680008479.0A patent/CN107205967B/zh active Active
- 2016-09-23 PL PL16778591.4T patent/PL3352745T3/pl unknown
- 2016-09-23 ES ES16778591T patent/ES2914060T3/es active Active
- 2016-09-23 JP JP2018515878A patent/JP6659833B2/ja active Active
- 2016-09-23 EP EP16778591.4A patent/EP3352745B1/en active Active
- 2016-09-23 WO PCT/US2016/053419 patent/WO2017053782A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| JP2018528251A (ja) | 2018-09-27 |
| US9597302B1 (en) | 2017-03-21 |
| CN107205967B (zh) | 2021-08-17 |
| JP6659833B2 (ja) | 2020-03-04 |
| CN107205967A (zh) | 2017-09-26 |
| US20170087105A1 (en) | 2017-03-30 |
| ES2914060T3 (es) | 2022-06-07 |
| EP3352745B1 (en) | 2022-03-30 |
| WO2017053782A1 (en) | 2017-03-30 |
| EP3352745A1 (en) | 2018-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL266596A (en) | Causes, uses and methods of treating synovialitis | |
| IL256501B (en) | Causes, uses and methods of treating synuclein pathology | |
| IL259570A (en) | Combined therapy and their uses and methods | |
| IL258002A (en) | Cenicriviroc combination therapy for the treatment of fibrosis | |
| EP3151797A4 (en) | Methods and devices for treating the skin | |
| IL266047A (en) | Methods and preparations for the treatment of Fabry disease | |
| SI3261726T1 (sl) | Sestavek za zdravljenje aken | |
| GB2588261B (en) | Apparatus, use of the apparatus and arrangement | |
| SG11201803485UA (en) | Method for producing silazane-siloxane copolymers and the use of such copolymers | |
| IL253617A0 (en) | Snekribirock for the treatment of leprosy | |
| ZA201900984B (en) | Methods and compositions for the treatment of warts | |
| PL3713572T3 (pl) | Leczenie tachykardii | |
| GB201309882D0 (en) | Prevention and treatment of atrial fibrillation | |
| DK3313207T3 (en) | Compositions and methods for the treatment of malnutrition | |
| ZA201802501B (en) | Antagonists of il-17c for the treatment and/or prevention of atopic dermatitis | |
| PT3340975T (pt) | Formulação para o tratamento de acne | |
| IL255075A0 (en) | Assemblies for ophthalmic procedure and methods of using them | |
| GB2543130B (en) | Improved coatings and method of applying the same | |
| GB201617715D0 (en) | Methods for the treatment and prevention of ebola | |
| SG11201706369PA (en) | Compositions and methods for the treatment of mucositis | |
| GB201404998D0 (en) | Atrial fibrillation therapy | |
| GB201617591D0 (en) | Methods for the treatment and prevention of ebola | |
| GB201617590D0 (en) | Methods for the treatment and prevention of ebola | |
| GB201518489D0 (en) | Methods for the treatment and prevention of ebola | |
| PT3524255T (pt) | Composição para o tratamento do acne |